Maria Oliva-Hemker, MD
Dr. Maria Oliva-Hemker is Director of the Division of Pediatric Gastroenterology, Hepatology and Nutrition and the inaugural Stermer Family Professor of Pediatric Inflammatory Bowel Disease at the Johns Hopkins University School of Medicine (JHUSOM) in Baltimore, Maryland. She is also the Vice Dean for Faculty where she oversees an office that serves more than 5000 full-time and part-time SOM faculty.
Dr. Oliva is a highly recognized clinical researcher with hundreds of peer-reviewed publications and invited national and international talks. She is the first Hispanic woman to rise through the academic ranks at JHUSOM to be promoted to Professor with tenure. Dr. Oliva has held leadership positions in multiple organizations including NASPGHAN, AGA, AAP and the Crohn’s and Colitis Foundation. She is an editor-in-chief of the book "Your Child with Inflammatory Bowel Disease: A Family Guide for Caregiving." Dr. Oliva has received multiple honors including the AGA Pediatric Gastroenterology and Developmental Biology Section Research Mentor Award and the AAP Murray Davidson Award which recognizes an outstanding clinician, educator and scientist who has made a significant contribution to the field of pediatric gastroenterology and nutrition.
Financial relationships
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:Takeda PharmaceuticalsTopic:vedolizumab trialDate added:04/01/2025Date updated:04/01/2025Relationship end date:12/31/2024
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:Predict Immune IncTopic:IBD trialDate added:04/01/2025Date updated:04/01/2025
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:PfizerTopic:IBD transition of careDate added:04/01/2025Date updated:04/01/2025Relationship end date:12/31/2024
-
Attribution:SelfType of financial relationship:OtherIneligible company:Janssen Research & DevelopmentTopic:Guselkumab advisory boardDate added:04/01/2025Date updated:04/01/2025
-
Attribution:SelfType of financial relationship:OtherIneligible company:PrizerTopic:advisory boardDate added:04/01/2025Date updated:04/01/2025